Boston Scientific
Boston Scientific partners with physicians to continually advance the quality of patient care with innovative solutions so you can choose the right technology and the right technique for every patient – without compromise. Visit our booth and speak with a representative to learn more.
Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.
Theragenics
An industry pioneer & leader, Theragenics Celebrates 40 Years of Forward Thinking in the global supply of LDR brachytherapy seeds for the treatment of prostate cancer, intra-ocular malignancies, and other tumor types with radiosensitivity. To learn more about our industry benchmark recognized sources, TheraSeed® Pd-103 & AgX100® I-125, please visit www.theragenics.com.
Varian
Imagine a world free from the fear of cancer. We do, every day. That’s why at Varian, a Siemens Healthineers Company, we’re obsessed with creating simpler, more efficient, and more effective technologies to power new victories in cancer care. From afterloaders to applicators, and a range of software tools for planning LDR and HDR brachytherapy treatments, Varian technology helps you give your patients the treatments they need, exactly where they need it. To learn more about our solutions, go to http://www.varian.com.
IsoAid
As the manufacturer of Advantage™ I-125 and Pd-103 seeds for over 20 years, IsoAid specializes in providing Brachytherapy seeds for the treatment of prostate, ocular and breast cancer, as well as for diagnostic localization purposes. We are a full-service company you can always rely on, making seeds at the activity you request, custom-loading and delivering them faster than anyone in the industry. Through our exclusive partnership with Eye Physics we give you access to cutting edge eye plaques and planning services, which deliver many clinical advantages to you and your patients. High-activity seeds are custom-loaded using COMS or Eye Physics plaques. Our innovate Secure Strand™ cuts down significantly on seed migration for prostate patients and is now being used for RSL with great success. Our team of experts is dedicated to helping with every aspect of your program and is happy to serve as a complete resource for you. IsoAid is invested in the future of Brachytherapy and we look forward to introducing you to some exciting new advances very soon.
IsoRay
IsoRay develops innovative, targeted, personalized brachytherapy products that effectively treat many forms of cancer. IsoRay's proprietary isotope, Cesium Blu, has over 10 years of proven patient outcomes for the treatment of prostate cancer. Learn how one little seed is redefining modern brachytherapy at www.isoray.com.
C4 Imaging
C4 Imaging develops innovative medical devices that enable clinicians to personalize patient care through accurate image-guided procedures. The company's core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that has been encapsulated within a variety of implantable, biocompatible shells.
